Bristol-Myers Squibb Aktie News

Bristol Myers Squibb (BMY) has delivered a ~27% total return in three months, driven by topline growth and dividend strength. With the valuation rebound largely complete, BMY shifts from a high-conviction rerating to a balanced Hold, recommending disciplined profit-taking. Execution and regulatory risks remain around replacing Eliquis revenues, with CELMoDs and CAR-T progress critical to the lo...

Bristol Myers Squibb just announced an important partnership with Microsoft that involves AI. Intuitive Surgical has integrated AI real-time processing into its surgical robots, but that could be just the start.

Bristol-Myers Squibb (BMY) remains a Strong Buy as it accelerates Growth Portfolio revenues and executes strategic oncology expansion. BMY's collaboration with Janux Therapeutics positions it to enter the solid tumor market, leveraging TRACTr technology for long-term oncology growth. Camzyos delivered 89% YoY revenue growth and promising phase 3 SCOUT-HCM results, supporting potential label exp...

Janux Therapeutics said on Thursday it has entered a collaboration with Bristol Myers Squibb ​to develop a new cancer treatment, ‌sending its shares up more than 12% in premarket trading.

Stocks entered 2026 on a positive note before a global sell-off wiped out gains, driven by tariff tensions, a Greenland tug-of-war, and Japan's bond crisis. In this uncertain environment, dividends can offer security by providing steady income and downside resilience. Dividend safety requires looking beyond yield to factors such as reliability, growth, and consistency. SA Dividend Grades have d...

The S&P 500 index is near all-time highs and has a low dividend yield of 1.1%. The stock market is narrowly focused on a few large technology companies.

Dividend income ETFs simplify stock investing and give you plenty of cash flow. These ETFs tend to have high yields and diversified portfolios that prioritize blue-chip stocks.

Bristol Myers Squibb said on Tuesday it had signed an agreement with Microsoft to use the tech company's AI-enabled radiology platform to help speed up early detection of lung cancer.